SoftBank-backed Neumora bags $2.51 billion valuation in lackluster debut by September 15, 2023 0 Shares of Neumora Therapeutics , which is backed by Amgen and Japan's SoftBank , fell in their market debut on ...
Key Fractal From 2023 Says Bitcoin Price Is Still Bullish, But A Crash To $90,000 Could Be Coming June 16, 2025